Freedom to Operate for MedTech Startups: A Practical FTO Search Guide

2026-08-19 · Caduvo Team

A clearance search isn't about whether your device is patentable—it's about whether you can sell it without getting sued. Here's when a medtech startup needs a freedom-to-operate analysis, what it covers, and how to approach it.

You’ve got a polished prototype, a 510(k) on the horizon, and a lead investor asking about IP risk. Then someone mentions “freedom to operate.” If your first thought is “We have our own patents—we’re fine,” it’s time to rewind. Having a patent doesn’t mean you can sell your device without infringing someone else’s.

A freedom to operate analysis is the legal review that tells you whether commercializing your device in a specific market would step on valid, enforceable patents. For a medtech startup, skipping this step can turn a promising launch into a lawsuit.

What a Freedom to Operate Analysis Actually Is (and Isn’t)

A freedom to operate analysis answers one question: Can we make, use, sell, or import this device without infringing third-party patents? It’s not the same as a patentability search, which asks whether your invention is novel enough to earn its own patent. You can have a rock-solid patent on your own clever improvement and still infringe a broader patent that covers the underlying structure or method.

Think of it this way: Patentability is about getting a patent. Freedom to operate is about avoiding a lawsuit. They are separate workstreams, and they pull from different prior art. A patentability search looks at any public disclosure before your filing date. An FTO search looks only at in-force patents and published applications in the jurisdictions where you plan to sell.

An FTO search doesn’t stop at abstracts or titles. It dissects the claims—the numbered sentences at the end of a patent that define the legal boundary. Infringement is determined claim by claim. If your device does not include every element of a claim, or if you can argue non-infringement under the doctrine of equivalents, you may be in the clear. But that analysis requires a patent attorney, not a database report.

When a MedTech Startup Should Run an FTO Search

Timing matters. Run an FTO search too early, and you might not have a solid enough design to evaluate. Run it too late, and you’ve already sunk hundreds of thousands into tooling, clinical studies, or a regulatory submission built around a feature you can’t legally use.

The sweet spot: after you’ve frozen the core technical features but before you commit to expensive development milestones. For most startups, that means right before or right after a design freeze, and certainly before submitting a 510(k) or starting a clinical trial. Investors and strategic partners will ask for it. A clean FTO opinion can be a condition of closing a funding round or signing a licensing deal.

Repeat the analysis when you add features, enter a new geography, or discover a competitor’s recently issued patent. An FTO opinion is a snapshot in time. It doesn’t age gracefully.

What an FTO Search Covers (and Doesn’t)

A proper freedom to operate search includes:

• In-force utility patents and published patent applications (not just granted patents).
• Design patents if the look of your device matters.
• Method claims that cover how the device is used or implanted—not just the device itself.
• Searches across multiple data sources: claim language, patent classifications, and assignee records.

It does not cover:

• Trade secrets, copyrights, or trademarks.
• Regulatory exclusivity (e.g., data exclusivity for a drug, which rarely applies to devices).
• Patents that have expired or been abandoned, unless they could be revived.

The search is jurisdiction-specific. A patent that blocks you in the U.S. may not exist in Europe, and vice versa. Most medtech startups start with a U.S. FTO search and expand from there.

How FTO Fits with FDA Strategy and Reimbursement

FTO is a legal question, but it collides with regulatory and reimbursement decisions. If you find a blocking patent and design around it, you might change the device enough to alter your predicate device selection or even your FDA classification. A small mechanical change can shift a submission from a straightforward 510(k) to a more complex De Novo.

On the reimbursement side, a blocked feature could be the very thing that differentiates your device in the eyes of a value analysis committee. If you have to strip out a novel sensing mechanism, your medical device reimbursement narrative might lose its edge. Coordinate early with regulatory and market-access leads. While Caduvo helps you map the reimbursement and coding landscape, FTO is a separate legal process that requires a patent attorney.

Typical Costs and What You Get

A formal freedom to operate opinion from a registered patent attorney typically costs $15,000 to $50,000 or more, depending on the technology’s complexity and the number of claims involved. A single device with a straightforward mechanical design might come in at the lower end of that range. A software-enabled surgical system with multiple subsystems can push the cost higher.

What you get for that spend:

• A list of relevant patents and applications identified through a structured search.
• A claim-by-claim infringement analysis for the most pertinent patents.
• A written opinion letter that outlines the risks and recommended next steps.

Some firms offer a preliminary “knock-out” search for a few thousand dollars. That can flag obvious problems early, but it’s not a substitute for a full opinion. If you’re raising capital or negotiating with a strategic, expect the full analysis.

Design-Around Strategies When You Find a Problem

Finding a blocking patent isn’t the end of the road. You have options:

1. Design around the claims. Modify the device so it no longer meets every limitation of the independent claims. This is often the most cost-effective path, but it takes engineering time and can trigger a regulatory ripple effect.
2. Challenge the patent’s validity. If you have strong prior art the examiner never saw, you can file an inter partes review (IPR) or a post-grant review. This is expensive and adversarial, but it can clear the field.
3. Negotiate a license. Approach the patent owner. Worst case, you pay a royalty. Best case, the patent is about to expire and you can license it for a song.
4. Acquire the patent. Sometimes a startup will buy a blocking patent to remove the threat entirely. That’s a balance-sheet decision.
5. Wait it out. If the patent expires in 18 months and you can afford to delay launch, you might simply outlast it. But map the expiration dates carefully, including any patent term adjustments.

Each path has a cost, a timeline, and a regulatory consequence. Factor them into your product roadmap before you commit to a design.

Actionable Takeaways

• Run a freedom to operate search after design freeze—before you spend heavily on clinical, regulatory, or tooling.
• Remember: an FTO analysis is about the claims, not the patent title or abstract. It’s a legal opinion, not a database search.
• Coordinate FTO findings with your regulatory strategy. A design-around can change your predicate device or device classification.
• Budget $15,000–$50,000 for a formal opinion. A knock-out search is cheaper but not a replacement.
• If you find a blocking patent, don’t ignore it. Design around, challenge, license, or wait—but decide with eyes open.